At-School Vaccination Boosts HPV Vaccination Coverage
By Lori Solomon HealthDay Reporter
THURSDAY, May 30, 2024 -- At-school vaccination may be a useful tool to increase human papillomavirus (HPV) vaccination coverage among adolescents, according to a study published online May 23 in JAMA Network Open.
Nathalie Thilly, Ph.D., from Université de Lorraine in Nancy, France, and colleagues examined the effectiveness of a three-component intervention (education of adolescents and their parents, the training of providers, and free vaccination at school) on HPV vaccination coverage among adolescents (aged 11 to 14 years). The analysis included 30,739 adolescents.
The researchers found that the median vaccination coverage increased by 4.0 to 14.2 percentage points at two months after the intervention. There was a significant increase in vaccination coverage with at-school vaccination (5.50 percentage points). There was no effect on vaccine coverage with adolescents’ education and motivation (−0.08 percentage points) and general practitioners' (GPs') training (−1.46 percentage points). At-school vaccination had a higher effect when access to GPs was poor.
"Regarding the primary outcome, it is possible that the time horizon was too short to highlight the benefits of the education and motivation and GPs' training components," the authors write. "They require that parents schedule two visits with their GP (one for the vaccine prescription and one for the vaccination) and they may delay one or both visits until they have another reason to consult their GP."
Several authors disclosed ties to pharmaceutical companies.
Disclaimer: Statistical data in medical articles provide general trends and do not pertain to individuals. Individual factors can vary greatly. Always seek personalized medical advice for individual healthcare decisions.
© 2024 HealthDay. All rights reserved.
Posted May 2024
Read this next
Guidelines Address RT for Management of HPV-Linked Oropharyngeal Cancer
FRIDAY, June 28, 2024 -- In a clinical practice guideline issued by the American Society for Radiation Oncology and published online June 18 in Practical Radiation Oncology...
COVID-19 Vaccination Not Tied to Adverse Pregnancy Outcomes
TUESDAY, June 25, 2024 -- mRNA COVID-19 vaccination during pregnancy is not associated with an increased risk of adverse pregnancy outcomes, according to a study published in the...
FDA Approves Capvaxive Pneumococcal 21-Valent Conjugate Vaccine
FRIDAY, June 21, 2024 -- The U.S. Food and Drug Administration has approved the Capvaxive pneumococcal 21-valent conjugate vaccine for the prevention of invasive pneumococcal...
More news resources
- FDA Medwatch Drug Alerts
- Daily MedNews
- News for Health Professionals
- New Drug Approvals
- New Drug Applications
- Drug Shortages
- Clinical Trial Results
- Generic Drug Approvals
Subscribe to our newsletter
Whatever your topic of interest, subscribe to our newsletters to get the best of Drugs.com in your inbox.